クリティカルケア診断市場- 世界の産業規模、シェア、動向、機会、予測：検査タイプ別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

クリティカルケア診断の世界市場規模は2024年に13億3,000万米ドルとなり、2030年までのCAGRは5.11%で予測期間中に大きく成長すると予測されています。

同市場は、クリティカルケア環境における迅速かつ正確な診断ツールへのニーズの高まりにより、急速に発展しています。世界の慢性疾患の増加と高齢化により、敗血症、心疾患、呼吸器疾患、臓器不全などの急性疾患の有病率は急速に上昇しています。この増加は、早期発見と効率的な介入が可能な高度診断の必要性を強調しています。例えば、米国の65歳以上の高齢者人口は2022年の5,800万人から2050年には8,200万人に増加し、総人口の17%から23%に増加すると予想されており、人口動態の急激な変化がクリティカルケア・サービスの需要を高めています。

市場促進要因

重症患者の増加

主な市場課題

高度診断のコスト

主な市場動向

分子診断学の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のクリティカルケア診断市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 検査タイプ別（フローサイトメトリー、血液学検査、微生物学および感染検査、凝固検査、免疫タンパク質検査、ルーチンおよび特殊化学検査、その他）
  • エンドユーザー別（手術室、救急室、集中治療室、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のクリティカルケア診断市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のクリティカルケア診断市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のクリティカルケア診断市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のクリティカルケア診断市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのクリティカルケア診断市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収

第13章 世界のクリティカルケア診断市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替治療法の脅威

第15章 競合情勢

• Neoplas med GmbH
• U.S. Medical Innovations
• Terumo Medical Corp
• Adtec Plasma Technology Co Ltd
• Apyx Medical Corp
• Nordson Corp
• Europlasma NV
• Terraplasma GmbH
• Henniker Plasma
• Smith & Nephew plc

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Critical Care Diagnostics Market was valued at USD 1.33 billion in 2024 and is projected to grow significantly during the forecast period with a CAGR of 5.11% through 2030F. This market is rapidly evolving, driven by an increasing need for prompt and precise diagnostic tools in critical care environments. With a global rise in chronic diseases and an aging population, the prevalence of acute conditions such as sepsis, cardiac disorders, respiratory diseases, and organ failure is climbing rapidly. This growth underscores the necessity for advanced diagnostics capable of early detection and efficient intervention. For example, the U.S. population aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, growing from 17% to 23% of the total population, illustrating a sharp demographic shift that intensifies demand for critical care services.

Key Market Drivers

Increasing Incidence of Critical Illnesses

A major driver of growth in the critical care diagnostics market is the rising occurrence of severe medical conditions globally. As populations continue to age and lifestyle patterns evolve, conditions such as sepsis, cardiac and respiratory disorders, and organ failure are becoming more widespread. This has amplified the demand for cutting-edge diagnostic technologies that enable swift and accurate identification of these illnesses. Timely diagnosis is essential in critical care as it facilitates early intervention, thereby improving patient recovery and survival rates. According to the World Health Organization (WHO), approximately 422 million individuals were living with diabetes in 2023, predominantly in low- and middle-income countries. With around 1.5 million annual deaths directly attributed to diabetes, the need for early detection and effective management solutions is particularly pressing in resource-limited settings.

Key Market Challenges

Cost of Advanced Diagnostics

One of the foremost challenges in the critical care diagnostics market is the high cost associated with advanced diagnostic technologies. The growing prevalence of life-threatening health conditions, including sepsis, cardiac and respiratory diseases, and organ failure, is fueling the demand for these innovations. However, the financial burden of acquiring and maintaining such sophisticated diagnostic equipment is considerable. This poses a challenge particularly for healthcare providers operating in resource-constrained regions. Additionally, the aging global population adds further pressure on healthcare systems, making cost-effectiveness a crucial factor in the adoption of diagnostic solutions, especially in public and rural healthcare settings.

Key Market Trends

Advancements in Molecular Diagnostics

Technological progress in molecular diagnostics is shaping a key trend in the critical care diagnostics landscape. This approach analyzes genetic material and other molecular indicators to identify diseases, pathogens, or mutations with high precision. The deeper understanding of genetic factors in disease development has allowed for more accurate and personalized diagnostic techniques. Molecular diagnostics enables detection of illnesses at a cellular level, thereby improving diagnostic accuracy and facilitating tailored treatment plans based on individual genetic profiles. This innovation is redefining diagnostic capabilities in critical care by enhancing both speed and specificity of disease identification.

Key Market Players

• Neoplas med GmbH
• U.S. Medical Innovations
• Terumo Medical Corp
• Adtec Plasma Technology Co Ltd
• Apyx Medical Corp
• Nordson Corp
• Europlasma NV
• Terraplasma GmbH
• Henniker Plasma
• Smith & Nephew plc

Report Scope:

In this report, the Critical Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Critical Care Diagnostics Market, Test Type:

• Flow Cytometry
• Hematology Test
• Microbiology and Infectious Test
• Coagulation Test
• Immunoprotein
• Routine and Special Chemistry
• Others

Critical Care Diagnostics Market, End User:

• Operating Room
• Emergency Room
• Intensive Care Unit
• Other

Critical Care Diagnostics Market, By Region:

• North America

United States

Canada

Mexico

• Europe

Germany

United Kingdom

Italy

France

Spain

• Asia Pacific

China

India

Japan

South Korea

Australia

• South America

Brazil

Argentina

Colombia

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Critical Care Diagnostics Market.

Available Customizations:

Critical Care Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Critical Care Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Flow Cytometry, Hematology Test, Microbiology and Infectious Test, Coagulation Test, Immunoprotein, Routine, and Special Chemistry, and Others)
  • 5.2.2. By End User (Operating Room, Emergency Room, Intensive Care Unit, and Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Critical Care Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Critical Care Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Critical Care Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Critical Care Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By End User

7. Europe Critical Care Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Critical Care Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Critical Care Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Critical Care Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By End User
  • 7.3.4. France Critical Care Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Critical Care Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Critical Care Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Critical Care Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Critical Care Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Critical Care Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Critical Care Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Critical Care Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By End User

9. South America Critical Care Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Critical Care Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Critical Care Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Critical Care Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Critical Care Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Critical Care Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Critical Care Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Critical Care Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions

13. Global Critical Care Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

• 15.1. Neoplas med GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. U.S. Medical Innovations
• 15.3. Terumo Medical Corp
• 15.4. Adtec Plasma Technology Co Ltd
• 15.5. Apyx Medical Corp
• 15.6. Nordson Corp
• 15.7. Europlasma NV
• 15.8. Terraplasma GmbH
• 15.9. Henniker Plasma
• 15.10. Smith & Nephew plc

16. Strategic Recommendations

17. About Us & Disclaimer